Publications
29
Citations
435
Est. group size
—
Recurring co-author estimate
Active years
22
Publishing since 2004
Typically publishes in teams of ~10 · 0% small-team papers (≤3 authors) · across 8 venues
- Long-term effects of simulated microgravity in the central nervous system of rhesus monkeys: a voxel-wise multimodal MRI study
Frontiers in Physiology · 2025
- Sepiolite Impact on Reservoir Quality of Tight Argillaceous Limestones in Mid-Permian Maokou Formation in Sichuan Basin, Sw China
SSRN Electronic Journal · 2024
- AIGV-Assessor: Benchmarking and Evaluating the Perceptual Quality of Text-to-Video Generation with LMM
arXiv (Cornell University) · 2024
- GAIA: Rethinking Action Quality Assessment for AI-Generated Videos
arXiv (Cornell University) · 2024
- Entropy-Based Parameterized Amplitude and Phase Correction for MIMO Ground-Based SAR
IEEE Transactions on Geoscience and Remote Sensing · 2024
- MA13.08 CHOICE-01: A Phase 3 Study of Toripalimab Versus Placebo in Combination With First-Line Chemotherapy for Advanced NSCLC
Journal of Thoracic Oncology · 2021
- 167TiP AdvanTIG-301: Anti-TIGIT monoclonal antibody (mAb) ociperlimab (OCI) + tislelizumab (TIS) + concurrent chemoradiotherapy (cCRT) followed by OCI + TIS or TIS + cCRT followed by TIS vs cCRT followed by durvalumab (DUR) in previously untreated, locally advanced, unresectable NSCLC
Annals of Oncology · 2021
- 1339P Efficacy and safety of MIL60, a bevacizumab biosimilar, in combination with paclitaxel/carboplatin in patients with advanced or recurrent non-squamous non-small cell lung cancer: A randomized, double-blind, multicenter phase III study
Annals of Oncology · 2021
- 60TiP ORIENTAL: An open label, multicenter, phase IIIb study of first-line durvalumab plus platinum-based chemotherapy in Chinese patients with extensive stage small cell lung cancer (ES-SCLC)
Journal of Thoracic Oncology · 2021
- Development and External Validation of Prognostic Nomograms in Hepatocellular Carcinoma Patients: A Population Based Study
HPB · 2021
- The Efficacy of Local Radiotherapy after Failure of First-Line Treatment for Piiia-N2 Non-Small Cell Lung Cancer
International Journal of Radiation Oncology*Biology*Physics · 2020
- Serial Circulating Tumor DNA for Evaluating Early Response During Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: Preliminary Analysis of a Prospective Biomarker Study
International Journal of Radiation Oncology*Biology*Physics · 2020
- Simple OS Risk Score Classification in Resected Pathological Stage IIIA-N2 Non-Small Cell Lung Cancer Patients before Postoperative Radiotherapy: A Prediction Model
International Journal of Radiation Oncology*Biology*Physics · 2019
- OA03.02 Effect of Anlotinib in Advanced Small Cell Lung Cancer Patients Previously Received Chemoradiotherapy: A Subgroup Analysis in ALTER 1202 Trial
Journal of Thoracic Oncology · 2019
- Can Convolutional Neural Network Delineate OAR in Lung Cancer More Accurately and Efficiently Compared with Atlas Based Method？
International Journal of Radiation Oncology*Biology*Physics · 2019
- Journal of Thoracic Oncology×6
- International Journal of Radiation Oncology*Biology*Physics×5
- Annals of Oncology×3
- arXiv (Cornell University)×2
- IEEE Transactions on Geoscience and Remote Sensing×1
- Claudia I. Henschke
Medicine · University of Michigan
- Wei Tang
Medicine · Indiana University
- Manny Coker‐Schwimmer
Medicine · The Ohio State University
- A. Foster
Medicine · Indiana University
- Robert E. Merritt
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile